In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients

Abdel Naser Zaid, Masshour Ghanem, Dua`a Shweiki, Hala Shtewi, Raja` Shaheen, Sondos Al Helaly, Zeina Khayyat, Rowa’a Al Ramahi, Saed Zyoud
  • Therapeutics and Clinical Risk Management, September 2016, Dove Medical Press
  • DOI: 10.2147/tcrm.s110727

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/tcrm.s110727

The following have contributed to this page: Abdel Naser Zaid and Dr Sa'ed Zyoud